TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women May 27, 1988
TCL Archive In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced August 3, 1990
TCL Archive NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It January 24, 1986
